BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/28/2014 5:50:00 PM | Browse: 777 | Download: 710
Publication Name World Journal of Gastroenterology
Manuscript ID 7377
Country Italy
Received
2013-11-15 15:44
Peer-Review Started
2013-11-19 09:11
To Make the First Decision
2013-12-26 10:44
Return for Revision
2013-12-26 17:18
Revised
2014-01-09 23:37
Second Decision
2014-01-20 17:42
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-01-20 18:28
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-03-25 09:07
Publish the Manuscript Online
2014-04-29 09:53
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Adjuvant chemotherapy for gastric cancer: Current evidence and future challenges
Manuscript Source Invited Manuscript
All Author List Rosalba Miceli, Gianluca Tomasello, Giacomo Bregni, Maria Di Bartolomeo and Filippo Pietrantonio
Funding Agency and Grant Number
Corresponding Author Rosalba Miceli, PhD, Unit of Medical Statistics, Biometry and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy. rosalba.miceli@istitutotumori.mi.it
Key Words Gastric cancer; Adjuvant chemotherapy; Radiotherapy; Randomized trial
Core Tip Despite the benefit of adjuvant therapy has been clearly demonstrated, no general consensus has been still reached on the best treatment option. The narrow therapeutic index of adjuvant chemotherapy requires a careful assessment of expected risks and benefits for individual patients. Many issues, such as the role of postoperative radiotherapy and the best chemotherapy regimen, are still under investigation. Moreover, no prognostic or predictive factors beyond pathological stage have been prospectively validated. Despite researchers’ efforts, this issue still represent an unmet medical need. In this review we describe the recently completed landmark studies and meta analyses, and we discuss the future challenges in this research field.
Publish Date 2014-04-29 09:53
Citation Miceli R, Tomasello G, Bregni G, Di Bartolomeo M, Pietrantonio F. Adjuvant chemotherapy for gastric cancer: Current evidence and future challenges. World J Gastroenterol 2014; 20(16): 4516-4525
URL http://www.wjgnet.com/1007-9327/full/v20/i16/4516.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i16.4516
Full Article (PDF) WJG-20-4516.pdf
Full Article (Word) WJG-20-4516.doc
Manuscript File 7377-Review.docx
Answering Reviewers 7377-Answering reviewers.pdf
Copyright License Agreement 7377-Copyright assignment.pdf
Peer-review Report 7377-Peer reviews.pdf
Scientific Editor Work List 7377-Scientific editor work list.doc